山东大学学报(医学版) ›› 2015, Vol. 53 ›› Issue (2): 48-51.doi: 10.6040/j.issn.1671-7554.0.2014.768
徐忠阳, 王立启, 徐振兴, 赵乾, 朱世明
XU Zhongyang, WANG Liqi, XU Zhenxing, ZHAO Qian, ZHU Shiming
摘要: 目的 探讨原发性高血压患者血清RhoA激酶(ROCK)水平与血压变异性(BPV)及颈动脉内膜中层厚度(IMT)的关系.方法 选取2013年9月至2014年8月山东大学附属济南市中心医院心内科原发性高血压患者73例,根据血清ROCK1水平分为高表达组(n=37)和低表达组(n=36).选取同期体检血压正常者40例为正常对照组.采用Human Rock1 Elisa kit及酶标仪检测血清ROCK1水平;监测24 h血压,记录24 h、白昼、夜间血压均值以及相应的血压标准差;采用彩色多普勒超声仪测量颈动脉IMT.结果 高表达组和低表达组血清ROCK1水平明显高于正常对照组(P<0.01);高表达组24 h收缩压标准差(24hSSD)、日间收缩压标准差(dSSD)、夜间收缩压标准差(nSSD)均明显高于低表达组(P<0.05);高表达组和低表达组颈动脉IMT比正常对照组明显增厚,高表达组颈动脉IMT比低表达组明显增厚(P<0.05);血清ROCK1水平与24hSSD、dSSD、nSSD及颈动脉IMT呈显著正相关性(P<0.05).结论 高血压患者血压变异性增高与RhoA/ROCK1信号通路高表达有关,RhoA/ROCK1信号通路过度激活可导致颈动脉IMT增厚及颈动脉粥样硬化斑块(AS)形成.
中图分类号:
| [1] 宫丽丽, 方莲花, 杜冠华. 心血管疾病治疗的新靶点—Rho激酶[J]. 中国药学杂志, 2008, 43(1):1-4. [2] Wibberley A, Chen Z, Hu E, et al. Expression and functional role of Rho-kinase in rat urinary bladder smooth muscle[J]. Br J Pharmacol, 2003, 138(5):757-766. [3] Zhou Q, Gensch C, Liao JK. Rho-associated coiled-coil-forming kinases (ROCKs): potential targets for the treatment of atherosclerosis and vascular disease[J]. Trends Pharmacol Sci, 2011, 32(3):167-173. [4] Mueller BK, Mack H, Teusch N. Rho-kinase: a promising drug target for neurological disorders[J]. Nat Rev Drug Discov, 2005, 4(5):387-398. [5] Gao HC, Zhao H, Zhang WQ, et al. The role of the Rho/Rock signaling pathway in the pathogenesis of acute ischemic myocardial fibrosis in rat models[J]. Exp Ther Med, 2013, 5(4):1123-1128. [6] 蔡茜, 吴尚洁, 赵雪峰. 慢性阻塞性肺疾病相关性肺动脉高压患者外周血单核细胞Rho激酶水平测定[J]. 中南大学学报:医学版, 2012, 37(5):453-457. CAI Qian, WU Shangjie, ZHAO Xuefeng. Measurement of Rho-kinase in peripheral blood monocytes in patients with pulmonary arterial hypertension related to chronic obstructive pulmonary diseases[J]. J Cent South Univ:Med Sci, 2012, 37(5):453-457. [7] Nakagawa O, Fujisawa K, Ishizaki T, et al. ROCK-I and ROCK-II, two isoforms of Rho-associated coiled-coil forming protein serine/threonine kinase in mice[J]. FEBS Lett, 1996, 392(2):189-193. [8] Somlyo AP, Somlyo AV. Ca2+ sensitivity of smooth muscle and nonmuscle myosin II; modulated by G proteins, kinases, and myosin phosphatase[J]. Physiol Rev, 2003, 83(4):1325-1358. [9] Somlyo AP, Somlyo AV. Signal transduction by G proteins, Rhokinase and protein phosphatase to smooth muscle and non-musclemyosin II[J]. J Physiol, 2000, 522(2): 177-185. [10] Mukai Y, Shimokawa H, Matoba T. Involvement of Rho-kinase in hypertensive vascular disease: a novel therapeutic target in hypertension[J]. FASEB J, 2001, 15(6):1062-1064. [11] Ito K, Hirooka Y, Sakai K, et al. Rho/Rho-kinase pathway in brain stem contributes to blood pressure regulation via sympathetic nervous system: possible involvement in neural mechanisms of hypertension[J]. Circ Res, 2003, 92(12):1337-1343. [12] Mancia G, Grassi G. Mechanisms and clinical implications of blood pressure variability[J]. J Cardiovasc Pharmacol, 2000, 35(4):15-19. [13] 胡建新, 胡宪珍, 张润香, 等. 血压变异性与血浆一氧化氮、内皮素含量的关系[J]. 江西医学院学报, 2004, 44(5):38-39. HU Jianxin, HU Xianzhen, ZHANG Runxiang, et al.The relationship between blood pressure variability and the plasma levels of nitric oxide and endothelin-1[J]. Acta Academiae Medicinae Jiangxi, 2004, 44(5):38-39. [14] Shibasaki M, Durand S, Davis SL, et al. Endogenous nitric oxide attenuates neutrally mediated cutaneous vasoconstriction[J]. J Physiol, 2007, 585(2):627-634. [15] Alexander J S. Rho, tyrosine kinase, Ca2+, and junctions in endothelial hyperpermeability[J]. Circ Res, 2000, 87(4):268-271. [16] Worthylake RA, Lemoine S, Watson JM, et al. RhoA is required for monocyte tail retraction during transendothelial migration[J]. J Cell Biol, 2001, 154(1):147-160. [17] 刘春南, 余首先, 赵晓宇. Rho激酶在心血管疾病中新进展及Rho激酶抑制剂的应用[J]. 心脏杂志, 2012, 24(4):521-524. LIU Chunnan, YU Shouxian, ZHAO Xiaoyu, et al. Rho kinase in cardiovascular diseases and applications for Rho kinase inhibition:Current progress[J]. Chin Heart J, 2012, 24(4):521-524. [18] Sander D, Kukla C, Klingelhfer J, et al. Relationship between circadian blood pressure patterns and progression of early carotid atherosclerosis: A 3-year follow-up study[J]. Circulation, 2000, 102(13):1536-1541. |
| [1] | 吴逸南 葛志明 李方 贺红 姜虹 张运. 自发性高血压大鼠肾脏血管紧张素转换酶2的表达[J]. 山东大学学报(医学版), 2209, 47(6): 5-. |
| [2] | 孙红林,管玉强,于培儒,李磊,杜庆霞,丁浩. 支架植入治疗儿童主动脉缩窄并高血压的可行性及近中期疗效[J]. 山东大学学报 (医学版), 2026, 64(4): 58-62. |
| [3] | 段盈竹,董波,于睿. 内在情感与类风湿关节炎患者冠状动脉粥样硬化风险关系的孟德尔随机化分析[J]. 山东大学学报 (医学版), 2026, 64(4): 63-71. |
| [4] | 李习平,邱梅,黄瑞峰,林慧慧,刘丝丝,罗鸿莹,王宇月,王敏,杨晓彤. 基于脂质沉积抑制-代谢清除协同效应的黄连素抗动脉粥样硬化机制研究进展[J]. 山东大学学报 (医学版), 2025, 63(9): 77-83. |
| [5] | 王宁,郝秀梅,牛翔,黄金明,徐静雅. 中国中老年高血糖、血脂异常、高血压人群健康体检服务利用现状及影响因素[J]. 山东大学学报 (医学版), 2025, 63(7): 82-91. |
| [6] | 杜艾家,张曼,陈鹤,王丽新,尚应殊. 微小RNA-1270靶向调控血管生成素样蛋白7抑制巨噬细胞炎症和脂质蓄积[J]. 山东大学学报 (医学版), 2025, 63(2): 1-9. |
| [7] | 王瑞,于康,刘燕萍. 维生素K2与妊娠及妊娠相关疾病的研究进展[J]. 山东大学学报 (医学版), 2024, 62(8): 9-17. |
| [8] | 于晴晴,常开锋,李吉庆,张凯,付苹,刘晓雯,赵英淇,薛付忠. 中老年人群高血压在非甾体抗炎药暴露与心脑血管疾病风险关联中的中介分析[J]. 山东大学学报 (医学版), 2023, 61(8): 79-85. |
| [9] | 许天旗,常娜,张帅,李莎,矫秉轩,于鑫鑫,王锡明. 非酒精性脂肪肝识别基于CTA颈动脉高危斑块[J]. 山东大学学报 (医学版), 2023, 61(12): 36-43. |
| [10] | 韩梅,孟维静,陶子琨,杨希,徐雅琪,穆华夏,卜伟晓,王素珍,石福艳. 基于G-计算的高血压、抑郁在2型糖尿病与认知功能之间的因果多中介分析[J]. 山东大学学报 (医学版), 2023, 61(10): 101-108. |
| [11] | 吴虹,张正铎,唐延金,祁少俊,高希宝. 5-甲基四氢叶酸对大鼠动脉粥样硬化的潜在干预作用[J]. 山东大学学报 (医学版), 2022, 60(8): 6-13. |
| [12] | 邬雨洁,张明泉,纪永利,赵璐,王越,陈沙沙. 寒痉汤及其拆方对寒凝证高血压大鼠血清炎症因子、血管内皮功能及纤维化的影响[J]. 山东大学学报 (医学版), 2022, 60(6): 10-18. |
| [13] | 宋钰峰,宁豪,姚志刚,吴海虎,刘非凡,吕家驹. 肾上腺海绵状血管瘤临床及影像特征[J]. 山东大学学报 (医学版), 2022, 60(2): 37-42. |
| [14] | 吕岩红,张志勉. 2 809名体检人群中高血压与幽门螺杆菌感染的关联性[J]. 山东大学学报 (医学版), 2022, 60(2): 43-47. |
| [15] | 谢佳莹,祁佳,宋铭,李育林,王迪,贾旭,张薇,钟明,尚嫄嫄. 血清蛋白质β-折叠水平与冠心病的相关性[J]. 山东大学学报 (医学版), 2022, 60(1): 21-26. |
|
||